CarlosArnoldoFierroMD

Medicine/Pediatrics • Kansas City, KS

Physician

Join to view full profile

Dr. Fierro is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Fierro's full profile

Already have an account?

Office
Clinica Medica
226 N 7th St
Kansas City, KS 66101
Phone+1 913-342-2277

Fax+1 913-342-3662
Is this information wrong?

Education & Training

University of Kansas School of MedicineResidency, Internal Medicine/Pediatrics, 1998 - 2000
University of Kansas School of MedicineClass of 1998

Certifications & Licensure

KS State Medical License 2000 - 2024

Clinical Trials

Panblok H7 Vaccine Adjuvanted With AS03 or MF59 Start of enrollment: 2017 Sep 20
Completed
Phase 2
BARDA Securing Anthrax Immunity For the Elderly Start of enrollment: 2018 May 09
Completed
Phase 2
A Phase 1 Study to Evaluate Safety & Immunogenicity of rVSV-Nipah Virus Vaccine Candidate PHV02 in Healthy Adult Subjects Start of enrollment: 2022 Jan 10
Completed
Phase 1
Vaccination Trial of a Recombinant MVA-BN-WEV Vaccine in Healthy Adult Subjects Start of enrollment: 2019 Oct 07
Completed
Phase 1
Safety and Immunogenicity of the Bris10 M2SR and Sing2016 M2SR H3N2 Monovalent Influenza Vaccines Start of enrollment: 2019 Sep 03
Completed
Phase 1
Safety and Immunogenicity Study of H3N2 M2SR Monovalent Influenza Vaccine in Healthy Volunteers Start of enrollment: 2016 Jun 01
Completed
Phase 1
Safety and Immunogenicity of an Intranasal RSV Vaccine Expressing SARS-CoV-2 Spike Protein (COVID-19 Vaccine) in Adults Start of enrollment: 2021 Apr 12
Recruiting
Phase 1
A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 Start of enrollment: 2021 Sep 29
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

32 citations
A Double-Blind, Randomized, Placebo-Controlled Phase 1 Study of Ad26.ZIKV.001, an Ad26-Vectored Anti-Zika Virus Vaccine.
, , , , , , , , , , , , , , , , , , , , , , > ;Annals of Internal Medicine. 2021 Feb 16
21 citations
Immunogenicity and safety of MF59-adjuvanted quadrivalent influenza vaccine versus standard and alternate B strain MF59-adjuvanted trivalent influenza vaccines in olde...
Brandon Essink, Carlos Fierro, Jeffrey Rosen, Amparo L. Figueroa, Bin Zhang, Carole Verhoeven, Jonathan Edelman, Igor Smolenov> ;Vaccine. 2020 Jan 10

Journal Articles

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
Karen Kotloff, Stephen A Spector, Carlos Fierro, The New England Journal of Medicine

Press Mentions

Long-Term Studies of COVID-19 Vaccines Hurt by Placebo Recipients Getting ImmunizedFebruary 19th, 2021
‘Historic Achievement’: Local Clinical Research Company Assisted with Promising Moderna COVID-19 TrialNovember 16th, 2020

Other Languages

Spanish

Hospital Affiliations

The University of Kansas HospitalKansas City, Kansas

External Links

Clinical Trialshttp://www.jcct.com/